Mouse models of the G M2 gangliosidoses, Tay-Sachs and Sandhoff disease, are null for the hexosaminidase ␣ and ␤ subunits respectively. The Sandhoff (Hexb؊/؊) mouse has severe neurological disease and mimics the human infantile onset variant. However, the Tay-Sachs (Hexa؊/؊) mouse model lacks an overt phenotype as mice can partially bypass the blocked catabolic pathway and escape disease. We have investigated whether a subset of Tay-Sachs mice develop late onset disease. We have found that ϳ65% of the mice develop one or more clinical signs of the disease within their natural life span (n ‫؍‬ 52, P < 0.0001). However, 100% of female mice with repeat breeding histories developed late onset disease at an earlier age (n ‫؍‬ 21, P < 0.0001) and displayed all clinical features. Repeat breeding of a large cohort of female Tay 
INTRODUCTION
The G M2 gangliosidoses are severe human diseases characterised by the storage of G M2 ganglioside within lysosomes. They arise due to an inherited deficiency of ␤-hexosaminidase. There are two major ␤-hexosaminidase isoenzymes, (hexosaminidase A and B), and a minor form (hexosaminidase S). The three isoenzymes differ in their sub-unit composition comprising ␣␤, ␤␤ and ␣␣ subunits, respectively. Mutations in the ␣ subunit cause a deficiency of hexosaminidase A and S (Tay-Sachs disease), while mutations in the ␤ sub-unit gene causes a deficiency of hexosaminidase A and B (Sandhoff disease). Tay-Sachs (TS) 2 and Sandhoff (SH) disease both involve G M2 accumulation in the central nervous system (CNS), leading to progressive neurodegeneration. They occur at a collective frequency of 1-3:300,000 live births (Neufeld, 1991) . However, in the Ashkenazi Jews carrier frequencies are very high (1 in 30) compared with the general population (1 in 300).
